D-Index & Metrics Best Publications

D-Index & Metrics

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Immunology D-index 74 Citations 26,794 155 World Ranking 875 National Ranking 488
Medicine D-index 84 Citations 29,756 221 World Ranking 8007 National Ranking 4445

Overview

What is he best known for?

The fields of study he is best known for:

  • Cancer
  • Internal medicine
  • Immune system

His primary areas of investigation include Immunology, Antigen, Dendritic cell, Immune system and Antigen-presenting cell. Immunology and Interleukin 12 are frequently intertwined in his study. His Antigen research is multidisciplinary, relying on both Monoclonal antibody, Interferon and Antigen presentation.

His work deals with themes such as Interleukin 23, T cell, T helper cell, Immunity and Molecular biology, which intersect with Dendritic cell. His Antigen-presenting cell study combines topics in areas such as Interleukin 21, IL-2 receptor, Immune tolerance and Cell biology. His Multiple myeloma research includes elements of Cancer research and Immunopathology.

His most cited work include:

  • Antitumor activity of thalidomide in refractory multiple myeloma. (2200 citations)
  • Antigen-specific inhibition of effector T cell function in humans after injection of immature dendritic cells. (1286 citations)
  • Immune and Clinical Responses in Patients with Metastatic Melanoma to CD34+ Progenitor-derived Dendritic Cell Vaccine (788 citations)

What are the main themes of his work throughout his whole career to date?

His main research concerns Immunology, Multiple myeloma, Internal medicine, Immune system and Cancer research. His study in Antigen, Dendritic cell, Antigen-presenting cell, Natural killer T cell and Immunotherapy is carried out as part of his Immunology studies. CD40 is closely connected to Interleukin 12 in his research, which is encompassed under the umbrella topic of Natural killer T cell.

His biological study spans a wide range of topics, including Monoclonal gammopathy of undetermined significance, Monoclonal and Bone marrow. The various areas that Madhav V. Dhodapkar examines in his Internal medicine study include Gastroenterology, Surgery and Oncology. In his study, CD8 is inextricably linked to T cell, which falls within the broad field of Cancer research.

He most often published in these fields:

  • Immunology (64.08%)
  • Multiple myeloma (40.85%)
  • Internal medicine (34.51%)

What were the highlights of his more recent work (between 2018-2021)?

  • Multiple myeloma (40.85%)
  • Internal medicine (34.51%)
  • Cancer research (25.70%)

In recent papers he was focusing on the following fields of study:

Madhav V. Dhodapkar spends much of his time researching Multiple myeloma, Internal medicine, Cancer research, Oncology and Lenalidomide. His Multiple myeloma research incorporates elements of Chimeric antigen receptor, Disease, Immune system and Bone marrow. His study in Immune system is interdisciplinary in nature, drawing from both Antigen and Mass cytometry.

Immunology and Pathology are the main topics of his Bone marrow study. Madhav V. Dhodapkar undertakes multidisciplinary studies into Immunology and Childhood leukemia in his work. His Cancer research study combines topics from a wide range of disciplines, such as Cancer, Pomalidomide, T cell, Blockade and Cancer immunotherapy.

Between 2018 and 2021, his most popular works were:

  • Treatment of multiple myeloma: ASCO and CCO joint clinical practice guideline (74 citations)
  • Randomized Trial of Lenalidomide Versus Observation in Smoldering Multiple Myeloma. (52 citations)
  • Early alterations in stem-like/resident T cells, innate and myeloid cells in the bone marrow in preneoplastic gammopathy. (41 citations)

In his most recent research, the most cited papers focused on:

  • Cancer
  • Internal medicine
  • Immune system

Multiple myeloma, Internal medicine, Oncology, Cancer research and Lenalidomide are his primary areas of study. His Multiple myeloma research includes elements of Guideline and Antibody, Monoclonal antibody. His Antibody study deals with the bigger picture of Immunology.

He has included themes like Acquired immune system, T cell, Immune system, Antigen and Chimeric antigen receptor in his Cancer research study. His studies deal with areas such as Cancer cell, Monoclonal gammopathy of undetermined significance, Gammopathy and Bone marrow as well as Acquired immune system. Madhav V. Dhodapkar interconnects Standard of care and Bortezomib in the investigation of issues within Lenalidomide.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

Antitumor activity of thalidomide in refractory multiple myeloma.

Singhal S;Mehta J;Desikan R;Ayers D.
The New England Journal of Medicine (1999)

3339 Citations

Antigen-Specific Inhibition of Effector T Cell Function in Humans after Injection of Immature Dendritic Cells

Madhav V. Dhodapkar;Ralph M. Steinman;Joseph Krasovsky;Christian Munz.
Journal of Experimental Medicine (2001)

1627 Citations

Immune and Clinical Responses in Patients with Metastatic Melanoma to CD34+ Progenitor-derived Dendritic Cell Vaccine

Jacques Banchereau;A. Karolina Palucka;Madhav Dhodapkar;Susan Burkeholder.
Cancer Research (2001)

1237 Citations

Increased Expression of Interleukin 23 p19 and p40 in Lesional Skin of Patients with Psoriasis Vulgaris

Edmund Jd Lee;William L. Trepicchio;Judith L Oestreicher;Debra D Pittman.
Journal of Experimental Medicine (2004)

1004 Citations

Nivolumab in patients with relapsed or refractory hematologic malignancy: Preliminary results of a phase ib study

Alexander M. Lesokhin;Alexander M. Lesokhin;Stephen M. Ansell;Philippe Armand;Emma C. Scott.
Journal of Clinical Oncology (2016)

713 Citations

Dendritic cell function in vivo during the steady state: a role in peripheral tolerance.

Ralph M. Steinman;Daniel Hawiger;Kang Liu;Laura Bonifaz.
Annals of the New York Academy of Sciences (2003)

572 Citations

A Reversible Defect in Natural Killer T Cell Function Characterizes the Progression of Premalignant to Malignant Multiple Myeloma

Madhav V. Dhodapkar;Madhav V. Dhodapkar;Matthew D. Geller;David H. Chang;Kanako Shimizu.
Journal of Experimental Medicine (2003)

568 Citations

Sustained expansion of NKT cells and antigen-specific T cells after injection of α-galactosyl-ceramide loaded mature dendritic cells in cancer patients

David H. Chang;Keren Osman;John Connolly;Anjli Kukreja.
Journal of Experimental Medicine (2005)

553 Citations

Antitumor Monoclonal Antibodies Enhance Cross-Presentation of Cellular Antigens and the Generation of Myeloma-specific Killer T Cells by Dendritic Cells

Kavita M. Dhodapkar;Joseph Krasovsky;Barbara Williamson;Madhav V. Dhodapkar;Madhav V. Dhodapkar.
Journal of Experimental Medicine (2002)

532 Citations

Antigen-bearing immature dendritic cells induce peptide-specific CD8(+) regulatory T cells in vivo in humans.

Madhav V. Dhodapkar;Ralph M. Steinman.
Blood (2002)

512 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Madhav V. Dhodapkar

Kenneth C. Anderson

Kenneth C. Anderson

Harvard University

Publications: 186

Meletios A. Dimopoulos

Meletios A. Dimopoulos

National and Kapodistrian University of Athens

Publications: 134

Paul G. Richardson

Paul G. Richardson

Harvard University

Publications: 129

S. Vincent Rajkumar

S. Vincent Rajkumar

Mayo Clinic

Publications: 121

Nikhil C. Munshi

Nikhil C. Munshi

Harvard University

Publications: 114

Guido Kroemer

Guido Kroemer

Sorbonne University

Publications: 106

Shaji Kumar

Shaji Kumar

Mayo Clinic

Publications: 101

Morie A. Gertz

Morie A. Gertz

Mayo Clinic

Publications: 99

Steven P. Treon

Steven P. Treon

Harvard University

Publications: 89

Robert A. Kyle

Robert A. Kyle

Mayo Clinic

Publications: 85

Irene M. Ghobrial

Irene M. Ghobrial

Harvard University

Publications: 81

Bart Barlogie

Bart Barlogie

Icahn School of Medicine at Mount Sinai

Publications: 80

Teru Hideshima

Teru Hideshima

Dana-Farber Cancer Institute

Publications: 77

Jerome B. Zeldis

Jerome B. Zeldis

Bristol-Myers Squibb (Switzerland)

Publications: 71

Angela Dispenzieri

Angela Dispenzieri

Mayo Clinic

Publications: 70

Lorenzo Galluzzi

Lorenzo Galluzzi

Cornell University

Publications: 70

Trending Scientists

Gregory S. Fischer

Gregory S. Fischer

Worcester Polytechnic Institute

Russel E. Caflisch

Russel E. Caflisch

New York University

Michael A. E. Andersen

Michael A. E. Andersen

Technical University of Denmark

David V. McCalley

David V. McCalley

University of the West of England

Boris Fehse

Boris Fehse

Universität Hamburg

Wilco C. E. P. Verberk

Wilco C. E. P. Verberk

Radboud University Nijmegen

Spencer M. Whitney

Spencer M. Whitney

Australian National University

Benjamin Meder

Benjamin Meder

Heidelberg University

Daniel R. Parsons

Daniel R. Parsons

University of Hull

Ji Shen

Ji Shen

Chinese Academy of Sciences

Xiaoling Chen

Xiaoling Chen

Wuhan University

Harry W.M. Steinbusch

Harry W.M. Steinbusch

Maastricht University

Yoshimi Misu

Yoshimi Misu

Yokohama City University

Andrew H. Talal

Andrew H. Talal

University at Buffalo, State University of New York

Melanie J. Zimmer-Gembeck

Melanie J. Zimmer-Gembeck

Griffith University

Kazuomi Kario

Kazuomi Kario

Jichi Medical University

Something went wrong. Please try again later.